Target intelligence / Profile preview

E3 Ubiquitin Ligase (None)

Target
None
Molecular classification
Enzyme
01

Overview

E3 ubiquitin ligases are a large and diverse family of enzymes that play a central role in the ubiquitination process, which is a post-translational modification critical for regulating protein stability, function, and localization in eukaryotic cells. They act as the final component in a three-enzyme cascade—alongside E1 (ubiquitin-activating enzyme) and E2 (ubiquitin-conjugating enzyme)—to catalyze the transfer of ubiquitin from an E2 enzyme to specific lysine residues on substrate proteins. Ubiquitination regulates numerous cellular processes including protein degradation via the 26S proteasome, cell cycle progression, DNA repair, endocytosis, transcriptional regulation, and response to cellular stress. Dysregulation or mutation of E3 ligases is implicated in various diseases such as cancer. Inhibitors or modulators targeting specific disease-associated or dysregulated E3s are under investigation for drug development.

02

Mechanism of action

Inhibition or modulation of E3 ligase activity, or PROTAC-mediated degradation of target proteins

03

Biological functions

Protein degradation/stability controlCell cycleDNA repairSignalingUbiquitination
04

Disease associations

CancerNeurodegenerative diseaseImmune disorders
05

Safety considerations

Off-target effects due to the large number of E3 ligasesPotential for drug resistanceUnintended consequences of altering protein degradation pathways

Beyond the preview

Go deeper on E3 Ubiquitin Ligase (None).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on E3 Ubiquitin Ligase (None).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call